(Q30364914)

English

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.

scientific article

Statements

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost. (English)
Prasert Thongcharoen
Vinai Suriyanon
Robert M Paris
Chirasak Khamboonruang
Mark S de Souza
Silvia Ratto-Kim
Chitraporn Karnasuta
Lynn Baglyos
Raphaelle El Habib
Sanjay Gurunathan
Arthur E Brown
John G McNeil
Thai AIDS Vaccine Evaluation Group
1 September 2007

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit